Dog Degenerative Myelopathy: Welfare Through Disease Progression

Understanding welfare needs across the staged progression of canine degenerative myelopathy and how to maintain quality of life.

Key Facts

Degenerative myelopathy (DM) is a progressive neurodegenerative disease most common in German Shepherds and Corgis
A mutation in the SOD1 gene is strongly associated with DM — DNA testing can identify carriers
Disease progresses from hind limb ataxia to complete paralysis over 6 months to 3 years
DM is not painful — affected dogs remain alert and engaged even as mobility declines
Wheelchairs and harnesses significantly extend the active period and quality of life for affected dogs
No disease-modifying treatment exists — management is purely supportive and welfare-focused

Welfare Considerations

DM presents a unique welfare challenge because the dog's cognitive and emotional state remains fully intact as physical function declines. An alert, interested dog with progressive paralysis requires intensive supportive care to prevent secondary welfare harms: pressure sores from recumbency, urinary scalding from incontinence and the psychological distress of reduced social participation. The welfare burden falls heavily on owners and carers too, and burnout poses a real risk. Welfare-centred management stages care intensity to the degree of disability, uses mobility aids proactively rather than reactively and builds a realistic end-of-life plan before crisis forces the decision.

What You Can Do

DNA test breeding German Shepherds and Corgis for the SOD1 mutation to reduce prevalence over generations
Begin physiotherapy and hydrotherapy at first signs to maintain muscle mass and prolong the active stage
Introduce a dog wheelchair before complete paralysis — dogs adapt best when introduced during partial mobility
Use thick orthopaedic bedding and turn non-ambulatory dogs every 4 hours to prevent pressure sores
Manage urinary incontinence with scheduled expression, nappy use or urinary catheterisation to prevent scalding
Set quality-of-life benchmarks with your vet in advance and review them monthly as disease progresses